In short, liraglutide plays a protective role in the kidney and liver of DN rats by decreasing miR-34a expression, increasing SIRT1 levels, and inhibiting HIF-1a, Egr-1, and TGF-β1. The gene discussed is SIRT1; the disease is liver dysplastic nodule.